An environmental risk assessment for oseltamivir (Tamiflu®) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions
- 1 September 2009
- journal article
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 72 (6) , 1625-1634
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Meeting Report: Risk Assessment of Tamiflu Use Under Pandemic ConditionsEnvironmental Health Perspectives, 2008
- The environmental fate of the antiviral drug oseltamivir carboxylate in different watersScience of The Total Environment, 2008
- Reassessing the Risks of Tamiflu Use during a Pandemic to the Lower Colorado RiverEnvironmental Health Perspectives, 2008
- The war against influenza: discovery and development of sialidase inhibitorsNature Reviews Drug Discovery, 2007
- Antiviral Oseltamivir Is not Removed or Degraded in Normal Sewage Water Treatment: Implications for Development of Resistance by Influenza A VirusPLOS ONE, 2007
- Degradation of the antiviral drug oseltamivir carboxylate in surface water samplesInternational Journal of Environmental Analytical Chemistry, 2007
- Screening Method for Ecotoxicological Hazard Assessment of 42 Pharmaceuticals Considering Human Metabolism and Excretory RoutesEnvironmental Science & Technology, 2007
- Potential Risks Associated with the Proposed Widespread Use of TamifluEnvironmental Health Perspectives, 2007
- WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virusThe Lancet Infectious Diseases, 2007
- Screening Analysis of Human Pharmaceutical Compounds in U.S. Surface WatersEnvironmental Science & Technology, 2003